A physician-scientist at Stephenson Cancer Center at OU Medicine co-directed an international clinical trial that yielded findings considered unprecedented in the field of gynecological cancer. The study's findings were published Sunday in the New England Journal of Medicine.
The five-year grant will strengthen translational research, particularly in the area of treatment-resistant cancers, across the OU Health Sciences Center, the academic partner of OU Medicine.
An Oklahoma woman is one of the first patients outside of a clinical trial to experience the benefits of a new, non-surgical treatment for her chronic stuffy nose.
When patients are hospitalized for surgery or treatment of a medical condition, they face an additional concern: the risk of developing a blood clot. Because today’s hospital stays are much shorter than in the past, patients confront that risk after they return home.
The construction of a state-of-the-art medical tower at OU Medical Center has begun. This building is designed to meet an increasing demand for the highest level of care.